XML 47 R7.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2015
Mar. 31, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Dec. 31, 2014
Cash flows from operating activities            
Net income (loss) $ (2,069,876)   $ (1,929,370) $ (19,481,526) $ 5,608,478  
Adjustments to reconcile net income to cash provided by (used in) operating activities            
Stock based compensation expense       305,153 173,979  
Depreciation and amortization       4,716,177 2,981,393  
Gain on acquisition 0   (92,635) 0 (6,573,686)  
Loss on asset sale       63,410 0  
Gain on change in fair value of derivative liability (818,051)   0 (2,635,033) 0  
Deferred federal income tax   $ 5,306,000   5,306,000 0  
Reduction of contingent liability 0   (1,876,752) 0 (1,876,752)  
Changes in operating assets and liabilities            
Accounts receivable       1,879,150 (9,731,011)  
Allowance for doubtful accounts       2,810,146 (230,000)  
Notes receivable-related party       0 (3,150,000)  
Inventory       8,773,459 (6,269,253)  
Prepaid expenses       (924,216) (1,348,935)  
Costs in excess of billings       779,285 0  
Accounts payable       (8,858,058) 8,962,991  
Deferred revenue       (495,965) 0  
Other assets       0 (81,450)  
Net cash provided by (used in) operating activities       (7,762,018) (11,534,246)  
Cash flows from investing activities            
Acquisitions       (1,082,649) (30,164,464)  
Purchase of fixed assets       (1,159,488) (4,227,056)  
Proceeds from asset sales       4,500 0  
Notes receivable       (500,000) 0  
Net cash used in investing activities       (2,737,637) (34,391,520)  
Cash flows from financing activities            
Proceeds from sale of stock       23,557,553 15,803,000  
Payments on contingent consideration       0 (136,662)  
Payments on notes payable       (18,019,983) (10,469,474)  
Proceeds from note payable       2,305,277 41,372,315  
Proceeds from revolving note       74,801,900 0  
Payments on revolving note       (74,142,007) 0  
Debt issue cost       0 (2,452,157)  
Proceeds from exercise of common stock options and warrants       0 359,862  
Net cash provided by (used in) financing activities       8,502,740 44,476,884  
Net change in cash and cash equivalents       (1,996,915) (1,448,882)  
Cash and cash equivalents at beginning of the period   $ 6,017,076   6,017,076 2,678,628 $ 2,678,628
Cash and cash equivalents at end of period 4,020,161   1,229,746 4,020,161 1,229,746 6,017,076
SUPPLEMENTAL INFORMATION            
Cash paid for interest       2,835,681 1,600,117  
Cash paid for income taxes       0 80,158  
NON-CASH INVESTING AND FINANCING TRANSACTIONS            
Conversion of Series A Preferred Stock into common stock       17 689  
Dividends declared but not yet paid $ 401,951   $ 0 401,951 0  
Shares issued as payment       200,000 0  
Beneficial conversion feature for Series B Preferred stock       5,737,796 0  
Fair value of warrants issued with series B Preferred stock       7,028,067 0  
E-Source Holdings, LLC            
Cash flows from financing activities            
Payments on contingent consideration           $ (136,662)
NON-CASH INVESTING AND FINANCING TRANSACTIONS            
Note payable for acquisition of E-Source interest       0 854,050  
Additional paid in capital for acquisition of E-Source interest       $ 0 $ 1,790,745